Litigation Details for Jazz Pharmaceuticals, Inc. v. Avadel CNS Pharmaceuticals, LLC (D. Del. 2021)
✉ Email this page to a colleague
Jazz Pharmaceuticals, Inc. v. Avadel CNS Pharmaceuticals, LLC (D. Del. 2021)
| Docket | ⤷ Sign Up | Date Filed | 2021-11-10 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Gregory B. Williams |
| Jury Demand | Both | Referred To | |
| Patents | 6,228,398; 6,309,663; 6,419,960; 6,514,531; 6,913,768; 7,268,156; 8,101,209; 8,731,963 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Jazz Pharmaceuticals, Inc. v. Avadel CNS Pharmaceuticals, LLC
Biologic Drugs cited in Jazz Pharmaceuticals, Inc. v. Avadel CNS Pharmaceuticals, LLC
The biologic drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .
Details for Jazz Pharmaceuticals, Inc. v. Avadel CNS Pharmaceuticals, LLC (D. Del. 2021)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2022-11-04 | 142 | Decision C.A. No. 22-2159 (D.D.C.) | Distribution System and Method, U.S. Patent No. 8,731,963 (“the ‘963 Patent”). Jazz’s oxybate drugs are distributed…2) a “Patent Statement,” which represents that no existing patents listed in the FDA’s patent database…existing patent or why the existing patent is invalid. Id. § 355(b)(2)(A)(i)–(iv). 3 A Patent Certification…submitting a Patent Statement. On May 24, 2022, the FDA rejected Avadel’s Patent Statement. It…claimed by an existing method-of-use patent held by Jazz (the “Patent Decision”). On June 6, 2022, Avadel | External link to document |
| 2022-11-18 | 146 | Memorandum Opinion | alleges infringement of U.S. Patent Nos. 8,731,963 ("the '963 patent"), 10,758,488 ("…quot;the ' 488 patent"), 10,813 ,885 ("the ' 885 patent"), 10,959,956 ("…quot;the ' 956 patent"), 10,966,931 ("the ' 931 patent"), 11 ,077,079 ("the…the ' 079 patent"), and 11,147,782 ("the '782 patent"). 1 Before the Court is…quot; It is a bedrock principle of patent law that the claims of a patent define the invention to which | External link to document |
| 2022-12-27 | 166 | Letter | discovery deadlines related to U.S. Patent No. 8,731,963 (“the ʼ963 patent”) while this Court’s Order and … seven patents-in-suit from three different patent families. The ʼ963 patent is the only patent asserted…infringement or validity of the ʼ963 patent from either a patent or regulatory law perspective. …expected to opine on the ʼ963 patent is expected to opine on the formulation patents. Therefore, staying discovery…related to the ’963 patent, including the regulatory exclusivity relating to that patent, but regardless | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
